Prosecution Insights
Last updated: November 04, 2026
Application No. 18/708,850

MESOPOROUS SILICA CONTAINING ZINC OXIDE AND MANUFACTURING METHOD THEREOF

Non-Final OA §102
Filed
May 09, 2024
Priority
May 16, 2022 — RE 10-2022-0059769 +1 more
Examiner
BERNS, DANIEL J
Art Unit
1736
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Cen Co. Ltd.
OA Round
1 (Non-Final)
73%
Grant Probability
Favorable
1-2
OA Rounds
2m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
607 granted / 831 resolved
+8.0% vs TC avg
Strong +34% interview lift
Without
With
+33.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
34 currently pending
Career history
859
Total Applications
across all art units

Statute-Specific Performance

§101
4.2%
-35.8% vs TC avg
§103
38.2%
-1.8% vs TC avg
§102
19.8%
-20.2% vs TC avg
§112
31.4%
-8.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 831 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restriction Applicant’s 10/15/26 election without traverse of Group I (claims 1-4) is acknowledged. Claims 5-8 are withdrawn from further consideration per 37 CFR 1.142(b) as drawn to a nonelected Group, there being no allowable generic or linking claim. Information Disclosure Statement (“IDS”) Note: the 5/30/24 IDS’s lined-through citations were previously cited in the 5/9/24 IDS. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-3 are rejected under 35 U.S.C. 102(a)(1) as anticipated by KR10-2016-0107548 (2016) (incl. English machine transl’n, “EMT”) (“’548”). Regarding claim 1, ‘548 discloses spherical mesoporous zinc silicate (“MZS”) -i.e. mesoporous zincosilicate- in which ZnO is bound to the MZS surface and zinc (inferred to be zinc ions as claimed) is “mainly located in the core” (inferred to refer to locations within the mesopores as claimed). See ‘548 at, e.g., EMT boxed areas (esp. Ex. 1 & 4); Figs. 2-3. Note that while the above-detailed composition is an intermediate, an argument that a mere intermediate product cannot anticipate a claimed composition was expressly rejected by the CCPA in In re Mullin, 481 F.2d 1333, 1335 (CCPA 1973), which stated that “Appellants concede that claims 1-3 read upon the intermediate coating of [the] Haigis [prior art reference] that is to be sintered rather than thermoset[, but argue] that this intermediate [prior art] structure constitutes an “accidental” and “unwitting” duplication of their invention which has no recognized utility other than as an intermediate… [and thus] cannot be used as a reference against their claims. We disagree.” The CCPA went on to state that “The question of whether or not a reference can be regarded as prior art that describes a composition or structure as being an intermediate has been resolved in this court adverse to appellants’ position.” Mullin, 481 F.2d at 1335, citing In re Herbert, 461 F.2d 1390 (CCPA 1972). Regarding claim 2, the claim is understood as reciting a property of claim 1’s composition and is thus regarded as implicitly/inherently (MPEP 2112) being present given ‘548’s anticipation of claim 1’s composition. See also MPEP 2112.01. Regarding claim 3, ‘548 thereafter treats its surface-bound-ZnO-treated-MZS with CTAC (cetyltrimethylammonium chloride, whose cetyl group is hydrophobic) to form a shell atop the surface-bound ZnO (i.e. bound to said ZnO). See ‘548 at, e.g., EMT boxed areas (esp. Ex. 4). Claim Objection/Potentially Allowable Subject Matter Claim 4 is objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Regarding claim 4, ‘548 (the most pertinent prior art of record) discloses a surface area value far below the claimed range. See ‘548 at, e.g., Table 1 (MZS value). Note: Examiner attempted to reach multiple counsel of record on 10-23-26 to attempt to advance the application to allowance via Examiner’s Amendment; all of Examiner’s calls went unanswered. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to DANIEL BERNS whose telephone number is (469)295-9161. The examiner can normally be reached M-F 8:30-5:00 (Central). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anthony Zimmer can be reached at (571) 270-3591. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DANIEL BERNS/ October 23, 2026 Primary Examiner Art Unit 1736
Read full office action

Prosecution Timeline

May 09, 2024
Application Filed
Oct 27, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12779397
METHOD AND APPARATUS FOR CLEANING EXHAUST GAS
3y 9m to grant Granted Nov 03, 2026
Patent 12779433
SUPERABSORBENT POLYMER AND METHOD FOR PRODUCING THE SAME
3y 3m to grant Granted Nov 03, 2026
Patent 12759959
Processes Producing Alkali Hydroxides, Alkali Carbonates, Alkali Bicarbonates, and/or Alkaline Earth Sulfates
3y 9m to grant Granted Oct 13, 2026
Patent 12759960
Sodium Hydroxide Production with Carboxylic Acid and Sulfur Dioxide Intermediates
2y 6m to grant Granted Oct 13, 2026
Patent 12746506
System and Method of Treatment of Gas Contaminated with Hydrogen Sulfide and the Reduction of Hydrogen Sulfide Associated Odor
3y 0m to grant Granted Sep 29, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
73%
Grant Probability
99%
With Interview (+33.7%)
2y 8m (~2m remaining)
Median Time to Grant
Low
PTA Risk
Based on 831 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month